Novalab will present its latest products linked to continuous glucose (MCG) monitoring on Thursday.It will do so in a mini symposium, under the title ‘The MCG in the technological ecosystem of diabetes’, which will take place this Thursday, April 19 during the XXIX thirst congress.
The company will have a stand with its latest news in technology applied to diabetes, especially with Cellnovo micro-pumps as protagonists.
In the Novalab stand will be the new Dexcom G5, the only approved MCG system for non -adjuvant use from 2 years of age.
As for the Mini Symposium, it will be moderated by Edelmiro Luís Menéndez Torro, of the Central University Hospital of Asturias, and will have Rosa Yelmo Valverde, nurse from the Universiatio Ramón y Cajal Hospital;and Eva Solá Izquierdo, doctor of the Dr. Peset University Hospital, as speakers.
Both will address the issue of continuous glucose monitoring from different perspectives, on the one hand, and the Valverde will do so with the ‘MCG presentation something more than a figure’;While Dr. Solá Izquierdo will do it with the talk ‘The MCG ahead and not because he is scared’.
In addition, the new Dexcom G5 will be at the Novalab stand, available for both Apple and Android devices and the only approved MCG system for non -adjuvant use and from 2 years of age.
